Thalamic pleomorphic xanthoastrocytoma central nervous system World Health Organization grade 3

Pleomorphic xanthoastrocytoma (PXA) is a rare astrocytic tumor. According to the 2021 World Health Organization (WHO) classification of central nervous system (CNS) tumors, PXAs with 5 or more mitoses per 10 high-power fields are classified as CNS WHO grade 3. Imaging findings of PXA CNS WHO grade 3...

Full description

Saved in:
Bibliographic Details
Main Authors: Hirotaka Takita, MD, PhD, Taro Shimono, MD, PhD, Kosuke Nakajo, MD, PhD, Tsutomu Ichinose, MD, PhD, Sayaka Tanaka, MD, Junko Hirato, MD, PhD, Hayato Ikota, MD, PhD, Maciej Pas, MD, PhD, Haruna Sakamoto, MD, Shodai Hiramatsu, MD, Yukio Miki, MD, PhD
Format: Article
Language:English
Published: Elsevier 2025-07-01
Series:Radiology Case Reports
Subjects:
Online Access:http://www.sciencedirect.com/science/article/pii/S1930043325003292
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Pleomorphic xanthoastrocytoma (PXA) is a rare astrocytic tumor. According to the 2021 World Health Organization (WHO) classification of central nervous system (CNS) tumors, PXAs with 5 or more mitoses per 10 high-power fields are classified as CNS WHO grade 3. Imaging findings of PXA CNS WHO grade 3 have rarely been reported, and thalamic cases are particularly uncommon. We present a case of thalamic PXA CNS WHO grade 3. A 71-year-old male presented with progressive right hemiparesis over three months. Magnetic resonance imaging (MRI) revealed a mass lesion in the left thalamus. Due to rapid tumor growth causing obstructive hydrocephalus, he underwent urgent craniotomy for tumor resection. Histopathology confirmed a PXA CNS WHO grade 3. Postoperatively, the patient received 54 Gy of radiation therapy in 27 fractions. His right hemiparesis persisted. He was subsequently transferred to a rehabilitation hospital.
ISSN:1930-0433